November 15, 2021

Grifols is included on the Dow Jones Sustainability World Index

  • For the first time ever, Grifols has been included on the Dow Jones Sustainability World Index (DJSI World) while retaining its distinction on the Dow Jones Sustainability Europe Index (DJSI Europe)
  • Grifols is recognized among the top six biotechnology companies globally and is the only European firm in its industry to join the DJSI World. This year, the number of companies assessed in this sector increased by 46%
  • The DJSI, the world’s leading sustainability index, evaluates companies’ performance based on environmental, social and governance (ESG) criteria. In 2021, the index distinguished only 322 companies out of the more than 10,000 invited to take part 

Barcelona, November 15, 2021.- Grifols (MCE: GRF, MCE: GRF.P, NASDAQ: GRFS), a global healthcare company and leading manufacturer of plasma-derived medicines with a proven track record of more than 110 years contributing to people’s health and well-being, has been recognized for the second consecutive year among the world’s most sustainable companies by the Dow Jones Sustainability Indices (DJSI), the leading global sustainability index that evaluates companies’ environmental, social and governance (ESG) performance.

Grifols’ notable sustainability achievements in recent years have led to its first-ever distinction on the DJSI World Index, while to remain on the DJSI Europe Index, in which the company was first listed in 2020.  

Grifols is among the top six worldwide leaders in its sector and the only European firm in its segment to join the DJSI World Index. This year, the number of companies assessed in the biotechnology industry increased by 46%.

Grifols’ scores reflect its continuous improvement in all dimensions evaluated: Corporate Governance and Economic, Environmental and Social.

As co-CEOs Raimon Grifols and Víctor Grífols Deu observed, “Sustainability is a long-term commitment to which we have remained faithful since our origins. Grifols’ distinction on the Dow Jones Sustainability World Index is an important step forward and a major recognition of our constant efforts to drive growth based on transparency, the value of a job well done, ethical leadership and teamwork. We will continue to work in the same direction in  benefit of the thousands of patients around the world who need our life-saving therapies and solutions, as well as for the planet and society as a whole.”

For the elaboration of the Dow Jones Sustainability Index, S&P Dow Jones applies a transparent, rules-based constituent selection process based on companies’ S&P Global Corporate Sustainability Assessment (CSA). The CSA consists of an extended questionnaire assessing both public and non-public data submitted by participating companies. This year, more than 10,000 publicly traded companies were invited to participate in the S&P Global CSA.

Grifols has been recognized on the FTSE4Good Global, FTSE4Good Europe and FTSE4Good Ibex sustainability stock market indices since 2018, and on the Euronext Vigeo Europe 120 and Euronext Vigeo Eurozone 120 indices, based on the Vigeo Eiris assessment, since 2020.  In 2021, Grifols was also included on the Bloomberg Gender-Equality Index (GEI) in recognition of its commitment to addressing gender inequality.

All of Grifols’ sustainability information is public and available at Grifols | Sustainability